TNF Inhibitors Do Not Seem to Boost Cancer-Recurrence Rates

NEW YORK (Reuters Health)—Tumor necrosis factor (TNF) inhibitors do not appear to increase cancer-recurrence rates in patients with rheumatoid arthritis (RA), according to new findings from Sweden. TNF has both tumor-promoting and cancer-protective effects, so TNF inhibitors could conceivably affect the risk for cancer recurrence. However, few studies have reported the risk for cancer relapse... [Read More]

Source: The Rheumatologist - August 15, 2018 Category: Rheumatology Authors: Will Boggs, MD Tags: Conditions Rheumatoid Arthritis Cancer Rheumatoid Arthritis (RA) TNF inhibitors Source Type: research